Biogen (BIIB) Gets EU Approval for Rare Disease Drug Qalsody
Biogen BIIB announced that the European Commission (EC) has granted marketing approval to Qalsody for treating patients with amyotrophic lateral sclerosis...
archiveamyotrophic lateral sclerosis
